Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
Previous Meetings
GBCC 2024
Global Breast Cancer Conference 2024
08:00-08:45
Satellite Symposium 2
Room 1 (Vista 1+2)
Moderators
- Jung Han Yoon (Gwangju Hyundai Hospital, Korea)
Speakers
- Ribociclib, Pushing the Boundary of CDK4/6 InhibitorSoo Jung Lee (Kyungpook National Univ. Chilgok Hospital, Korea)
09:00-09:50
Junior Doctors Forum
Junior Doctors Forum
Room 4 (Walker 2)
Moderators
- Han-Byoel Lee (Seoul National Univ. Hospital, Korea)
Speakers
- Experiences with Successfully Organizing and Operating Education ProgramsYazan Masannat (Broomfield Hospital, United Kingdom)
- Fifteen-Year Journey of ASTRRA TrialWoochul Noh (Konkuk Univ. Medical Center, Korea)
09:00-10:15
Symposium 4
Immunotherapy Going Beyond the Current Limits
Room 1 (Vista 1+2)
Moderators
- Soo-Chin Lee (National Univ. Cancer Institute, Singapore (NCIS), Singapore)
- Kyung Hae Jung (ASAN Cancer Center, Korea)
Speakers
- Tailoring Post-Neoadjuvant Treatment in TNBC-Current Treatment and Future PerspectivesSung Hoon Sim (National Cancer Center, Korea)
- Overcoming Resistance of Immunotherapy in TNBC - Mechanism and Novel TreatmentSoo-Chin Lee (National Univ. Cancer Institute, Singapore (NCIS), Singapore)
- Expanding Immunotherapy Beyond TNBC - New Strategy in HER2 and ER Positive Breast CancerJee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea)
Panel Discussion 5
Confronting Unique Deterioration Caused by Estrogen Deprivation Therapy
Room 2 (Grand 1)
Moderators
- Matteo Lambertini (Univ. of Genova - IRCCS Policlinico San Martino Hospital, Italy)
- Beomseok Ko (ASAN Medical Center, Korea)
Speakers
- Addressing Sexual Health Disturbance During Endocrine Therapy: Unique Challenges Among Various Age GroupsTara Sanft (Yale School of Medicine, U.S.A.)
- Current Therapeutic Options for Fertility Preservation: Challenges AheadMatteo Lambertini (Univ. of Genova - IRCCS Policlinico San Martino Hospital, Italy)
- Leveraging Bone Health Issue in Women Receiving Endocrine Therapy: Practical Applications and Future PerspectivesSo-Youn Jung (National Cancer Center, Korea)
Symposium 5
Local Tumor Control in Metastatic Breast Cancer
Room 3 (Walker 1)
Moderators
- Jee Suk Chang (Yonsei Cancer Center, Korea)
- Kyubo Kim (Seoul National Univ. Bundang Hospital, Korea)
Speakers
- Role of SBRT in Oligometastasis and OligoprogressionJee Suk Chang (Yonsei Cancer Center, Korea)
- Tailored Radiotherapy of the Primary Site in Metastatic Breast CancerHaeyoung Kim (Samsung Medical Center, Korea)
- Optimal RT Approach for Intracranial MetastasisYutaro Koide (Aichi Cancer Center Hospital, Japan)
Nursing Session 1 (Kor.)
Present and Future of Breast Cancer Specialist Nurse
Room 5 (Art Hall)
Moderators
- Mi Young Kang (Daerim St. Mary Hospital, Korea)
- In Jeong Cho (Wonju Severance Christian Hospital, Korea)
Speakers
- The Experience of Breast Cancer Practice Nurses' Job PerformanceInsook Lee (Changwon National Univ., Korea)
- Present and Future of Specialist Breast Cancer Care NursesJayoung Ahn (ASAN Medical Center, Korea)
- Best Practice of Advanced Nurse Practitioner in Breast Cancer Patient CareByonghee Jeon (Yonsei Univ. Severance Hospital, Korea)
Oral Presentation 5
Oral Presentation 5
Room 6 (Grand 4)
Moderators
- Hae Jin Park (Hanyang Univ. College of Medicine, Korea)
- Sungmin Park (Chungbuk National Univ. Hospital, Korea)
10:05-11:45
Junior Doctors Debate
Junior Doctors Debate
Room 4 (Walker 2)
Moderators
- Tristen Park (Yale School of Medicine, U.S.A.)
- Han-Byoel Lee (Seoul National Univ. Hospital, Korea)
Speakers
- [Part 1: Voting by Roche (Sponsor of the JDF/JDD Session)] Patient Centricity, Value of Time for The PatientsHan-Byoel Lee (Seoul National Univ. Hospital, Korea)
- [Part 2: Debate on Topic #1] Can We Omit Radiation Therapy for Stage I, Luminal-Type Breast Cancer Undergoing a Breast-Conserving Surgery?Team 1 vs. Team 2
- [Part 3: Debate on Topic #2] Should Contralateral Risk-Reducing Mastectomy Be Offered for All Breast Cancer Patients with a Pathologic BRCA Mutation?Team 3 vs. Team 4
10:30-11:45
Symposium 6
Tumor Heterogeneity and Dynamics in Breast Cancer: Unveiling Insights through Tissue and Liquid Biopsies
Room 1 (Vista 1+2)
Moderators
- Christina Curtis (Stanford Univ., U.S.A.)
- Hyeong-Gon Moon (Seoul National Univ. Hospital, Korea)
Speakers
- Therapy Induced Tumor Evolution Represents a Novel Therapeutic TargetGordon Mills (Oregon Health Sciences Univ., U.S.A)
- Spatial and Temporal Dynamics in the Tumor Microenvironment through ImmunotherapyChristina Curtis (Stanford Univ., U.S.A.)
- Serial Circulating Tumor DNA Landscape Portraying Clonal EvolutionPedram Razavi (Memorial Sloan Kettering Cancer Center, U.S.A.)
Special Session: Policy on Breast Cancer
Bridging the Gap Between Guidelines and Real-World Practice
Room 2 (Grand 1)
Moderators
- Benjamin Anderson (Univ. of Washington, U.S.A.)
- Jeong Eon Lee (Samsung Medical Center, Korea)
Speakers
- Overview on the Treatment Diversity for Breast Cancer Worldwide (WHO)Benjamin Anderson (Univ. of Washington, U.S.A.)
- Asian Data on the Treatment DiversityTakashi Ishikawa (Tokyo Medical Univ., Japan)
- Closing the Gap in Radiotherapy Access in AsiaMei Ling Yap (Univ. of New South Wales, Australia)
- Age and National Disparities in the Decision-Making Process of Breast Cancer PatientsHee Jeong Kim (ASAN Medical Center, Korea)
Education Session 4
Less is More in Breast Cancer: Radiation Oncologists' Perspective
Room 3 (Walker 1)
Moderators
- Isabelle Kindts (AZ Groeninge, Belgium)
- Jin Hee Kim (Keimyung Univ. Dongsan Medical Center, Korea)
Speakers
- RT Omission in Low-Risk Elderly PatientsTimothy Whelan (McMaster Univ., Canada)
- RNI Issues in ypN0Jeanny Kwon (Chungnam National Univ. College of Medicine, Korea)
- Tumor Bed Boost - When and HowIsabelle Kindts (AZ Groeninge, Belgium)
Nursing Session 2 (Kor.)
Managements of Hair Loss and Skin Change for Breast Cancer Patients
Room 5 (Art Hall)
Moderators
- Eun-Young Jun (Daejeon Univ., Korea)
- Hyungran Lee (Kyung Hee Univ., Korea)
Speakers
- Management of Skin Changes in Breast Cancer PatientsKyungmin Na (Daerim St. Mary's Hospital, Korea)
- Effectiveness of Cooling Cap to Prevent Persistent Chemotherapy-Induced Alopecia Among Patients with Breast Cancer: A Randomized Controlled TrialJuhee Cho (SAIHST, Sungkyunkwan Univ., Korea)
- Experience of Scalp Cooling Among Breast CancerNayeon Kim (Samsung Medical Center, Korea)
Session on Digital Health
The New Era of Digital Leading Innovation in Healthcare
Room 6 (Grand 4)
Moderators
- Hyun Jo Youn (Jeonbuk National Univ., Korea)
- Eunsu Park (Lunit Care, Korea)
Speakers
- Tech & Patient-Centric Cancer CareEunsu Park (Lunit Care, Korea)
- HRS: Standard-Based Multi-Institutional Research PlatformSoo-Yong Shin (Kakao Healthcare, Korea)
- Digital Healthcare 2024: Age of Generative AIKoon-Ho Rha (Naver Healthcare, Korea)
12:00-12:45
Plenary Lecture 3
Room 1 (Vista 1+2)
Moderators
- Wonshik Han (Seoul National Univ. Hospital, Korea)
Speakers
- Lobular Carcinoma - Current Concepts and ControversiesTari King (Dana-Farber Brigham Cancer Center, U.S.A.)
13:00-13:45
Satellite Symposium 3
Room 1 (Vista 1+2)
Moderators
- Jin Seok Ahn (Samsung Medical Center, Korea)
Speakers
- The Promising Role of Pembrolizumab in Transforming the Landscape for eTNBCDae-Won Lee (Seoul National Univ. Hospital, Korea)
14:00-14:45
Plenary Lecture 4
Room 1 (Vista 1+2)
Moderators
- Dong-Young Noh (CHA Gangnam Medical Center, Korea)
Speakers
- Origins, Evolution, and Clinical Implications of the Integrative Breast Cancer SubtypesChristina Curtis (Stanford Univ., U.S.A.)
15:00-16:15
Symposium 7
Neoantigen-Based Personalized Therapy
Room 1 (Vista 1+2)
Moderators
- Eui-Choel Shin (KAIST, Korea)
- Hee Jin Lee (ASAN Medical Center, Korea)
Speakers
- Neoantigen AnalysisSangwoo Kim (Yonsei Univ. College of Medicine, Korea)
- Neoantigen-Targeted VaccineSoonmyung Paik (Theragen Bio, Korea)
- Neoantigen-Targeted Cell TherapyHee Jin Lee (ASAN Medical Center, Korea)
Panel Discussion 6
Surgical Management for Individuals with Germline Mutation Carriers
Room 2 (Grand 1)
Moderators
- Isabel T. Rubio (Clinica Universidad de Navarra, Spain)
- Sang Uk Woo (Korea Univ. Guro Hospital, Korea)
Speakers
- Breast Conserving Surgery in Breast Cancer with BRCA1/2 Mutation CarriersTristen Park (Yale School of Medicine, U.S.A.)
- Is All Unilateral Breast Cancer with BRCA1/2 Mutation Carriers Recommended Contralateral Risk Reducing Mastectomy?Isabel T. Rubio (Clinica Universidad de Navarra, Spain)
- Risk Reducing Mastectomy Beyond BRCA1/2 Mutation CarriersSung-Won Kim (Daerim St. Mary's Hospital, Korea)
Education Session 5
Toxicity of Novel Agents: A Call for Attention
Room 3 (Walker 1)
Moderators
- Janice Tsang (The Univ. of Hong Kong, Hong Kong)
- Mastura MD Yusof (Pantai Hospital Kuala Lumpur, Malaysia)
Speakers
- Antibody Drug ConjugatesJanice Tsang (The Univ. of Hong Kong, Hong Kong)
- Targeted Therapeutics in Hormone Positive Breast CancersYoon-Sim Yap (National Cancer Centre Singapore, Singapore)
- Immunotherapies: Short and Long TermKyoung Eun Lee (Ewha Womans Univ. Mokdong Hospital, Korea)
Session on OPBS
Session on OPBS
Room 4 (Walker 2)
Moderators
- Tomoyuki Yano (Cancer Institute Hospital, Japan)
- Ho Yong Park (Kyungpook National Univ. Chilgok Hospital, Korea)
Speakers
- The Future of Oncoplastic Surgery: Innovations and Challenges in the Age of Personalized Breast Cancer SurgeryMee Hoong See (Universiti Malaya, Malaysia)
- Oncoplastic Surgery in the Modern Era: Balancing Surgical Outcomes with Patient SatisfactionJeeyeon Lee (Kyungpook National Univ. Chilgok Hospital, Korea)
- Considerations for Immediate Breast Reconstruction in Patients at High Risk of Radiation TherapyTomoyuki Yano (Cancer Institute Hospital, Japan)
- Surgical Difficulty of Nipple-Sparing Mastectomy and Reconstruction Based on Mastectomy Incision LocationHyun Ho Han (ASAN Medical Center, Korea)
GBCC-CACA Joint Session
The Strategy of HER-2 Positive Breast Cancer or New Drugs of Metastatic Breast Cancer
Room 5 (Art Hall)
Moderators
- Peng Yuan (National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences, China)
- Airi Han (Yonsei Univ. Wonju College of Medicine, Korea)
Speakers
- Advancements in Targeted Therapies: Managing HER2+ Metastatic Breast Cancer in Chinese PatientsPengfei Qiu (Shandong Cancer Hospital and Institute, China)
- Exploring Emerging Strategies: Addressing Triple-Negative Metastatic Breast Cancer in Korean PatientsKoung Jin Suh (Seoul National Univ. Bundang Hospital, Korea)
Panelists
- Lingzhi Xu (The Second Affiliated Hospital of Dalian Medical Univ., China)
- Sang Yull Kang (Jeonbuk National Univ. Hospital, Korea)
- Chang Ik Yoon (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
- Soo Jung Lee (Kyungpook National Univ. Chilgok Hospital, Korea)
- Heejung Chae (National Cancer Center, Korea)
- Huihua Xiong (Tongji Hospital, Tongji Medical College, Huazhong Univ. of Science and Technology, China)
- Hongyan Zhang (The Third Medical Center of PLA General Hospital, China)
16:30-17:45
Symposium 8
Antibody Drug Conjugates: Reshaping the Landscape of Breast Cancer Treatment
Room 1 (Vista 1+2)
Moderators
- Sarat Chandarlapaty (Memorial Sloan Kettering Cancer Center, U.S.A.)
- Kyong Hwa Park (Korea Univ. Anam Hospital, Korea)
Speakers
- Antibody-Drug Conjugates: The Evolution of Development and Current Landscape in Breast CancerKyong Hwa Park (Korea Univ. Anam Hospital, Korea)
- Unresolved Problem in Real-World Practice: Toxicities and Management of Brain MetastasesChun-Yu Liu (Taipei Veterans General Hospital, Taiwan)
- Future Directions: Resistance Mechanism of ADCs and Strategies to OvercomeSarat Chandarlapaty (Memorial Sloan Kettering Cancer Center, U.S.A.)
Special Session: Debate Session
Room 2 (Grand 1)
Moderators
- Jae Ho Jeong (ASAN Medical Center, Korea)
Speakers
- Do We Really Need to Use Neoadjuvant IO in ER+, eBC?Jee Hung Kim (Gangnam Severance Hospital, Korea)
- Do We Really Need to Use Neoadjuvant IO in ER+, eBC?Dae-Won Lee (Seoul National Univ. Hospital, Korea)
- What Is the Role of Adjuvant IO After Achieving pCR in eTNBC Following Neoadjuvant IO Treatment?Jee Hung Kim (Gangnam Severance Hospital, Korea)
- What Is the Role of Adjuvant IO After Achieving pCR in eTNBC Following Neoadjuvant IO Treatment?Dae-Won Lee (Seoul National Univ. Hospital, Korea)
Panelists
- DiscussionSeock-Ah Im (Seoul National Univ. Hospital, Korea)
- Matteo Lambertini (Univ. of Genova - IRCCS Policlinico San Martino Hospital, Italy)
- Soo-Chin Lee (National Univ. Cancer Institute, Singapore (NCIS), Singapore)
- Yeon Hee Park (Samsung Medical Center, Korea)
Education Session 6
Estrogen, Obesity, and Sarcopenia: Biology and Life Style
Room 3 (Walker 1)
Moderators
- Yen-Shen Lu (National Taiwan Univ. Hospital, Taiwan)
- Seeyoun Lee (National Cancer Center, Korea)
Speakers
- Obesity, Breast Cancer, and the Potential Mediating Effect of EstrogenJennifer Ligibel (Dana-Farber Cancer Institute, U.S.A.)
- Effect of Adjuvant Treatment on Obesity, Sarcopenia in Breast Cancer PatientsYoung-Jin Suh (The Catholic Univ. of Korea, St. Vincent's Hospital, Korea)
- The Role of Obesity and Sarcopenia in Anti-Cancer ImmunotherapyYen-Shen Lu (National Taiwan Univ. Hospital, Taiwan)
Session on HBOC
Session on HBOC
Room 4 (Walker 2)
Moderators
- Ava Kwong (The Univ. of Hong Kong, Hong Kong)
- Tae Hyun Kim (Inje Univ. Busan Paik Hospital, Korea)
Speakers
- Long-Term Outcome of BRCA1/2 Mutation with Breast Cancer in AsiaAva Kwong (The Univ. of Hong Kong, Hong Kong)
- Is It Time BRCA1/2 Genetic Test as a Companion Diagnosis of Breast Cancer?Seigo Nakamura (Showa Univ. School of Medicine, Japan)
- Gastric Cancer Risk and Management in BRCA1/2 MutationYoon Young Choi (Soonchunhyang Univ. Hospital Bucheon, Korea)
GBCC-JBCS Joint Session
Exploring Collaborative Research Opportunities
Room 5 (Art Hall)
Moderators
- Jong Han Yu (Samsung Medical Center, Korea)
- Shigehira Saji (Fukushima Medical Univ., Japan)
Speakers
- De-Escalation Therapy for Low-Risk HER2-Positive Early-Stage Breast CancerKazuki Nozawa (Aichi Cancer Center Hospital, Japan)
- Prognostic Impact of Adjuvant Endocrine Therapy by Age for Patients with T1a/bN0M0 ER-Positive and HER2-Negative Breast CancerYuko Takahashi (Okayama Univ. Hospital, Japan)
- Cohort Study of Asian Breast Cancer Patients with BRCA 1/2 Mutation (KoREa-BSG 06)Chihwan Cha (Hanyang Univ. College of Medicine, Korea)
- Prospective Single-Arm Study of Endocrine Therapies with Ovarian Function Suppression in Premenopausal Node-Positive Early Breast Cancer Patients with Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25)Sung Gwe Ahn (Gangnam Severance Hospital, Korea)
Panelists
- DiscussionYoung-Jin Lee (ASAN Medical Center, Korea)
- Takashi Ishikawa (Tokyo Medical Univ., Japan)
- Airi Han (Yonsei Univ. Wonju College of Medicine, Korea)